OTHER · Unmapped registry intervention
physiologic testing
Find medicine records ·
Find other trials using this name
Clinical trial
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
NCT00336102
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
PROCEDURE · Unmapped registry intervention
fatigue assessment and management
Find medicine records ·
Find other trials using this name
PROCEDURE · Unmapped registry intervention
management of therapy complications
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedThyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Fatigueunresolved
Hypothyroidismverified · MONDO: hypothyroidism
Interventions
physiologic testingOTHER
fatigue assessment and managementPROCEDURE
management of therapy complicationsPROCEDURE
Sponsors & collaborators
University of South Floridalead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
SpringfieldMissouri, United States3St LouisMissouri, United States2The BronxNew York, United States2AugustaGeorgia, United States2FargoNorth Dakota, United States2Royal OakMichigan, United States2TampaFlorida, United States1PhoenixArizona, United States1Winston-SalemNorth Carolina, United States1New OrleansLouisiana, United States1SpartanburgSouth Carolina, United States1ShreveportLouisiana, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00336102 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.